Text this: Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials

 _    _     _____     _  _     ______   __   __  
| \  / ||  |  ___||  | \| ||  /_   _//  \ \\/ // 
|  \/  ||  | ||__    |  ' ||   -| ||-    \   //  
| .  . ||  | ||__    | .  ||   _| ||_    / . \\  
|_|\/|_||  |_____||  |_|\_||  /_____//  /_//\_\\ 
`-`  `-`   `-----`   `-` -`   `-----`   `-`  --`